Selection and syntheses of tentacle type peptides as 'artificial' lectins against various cell-surface carbohydrates

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 1, 2007, Pages 511-517

  Hyun, Soonsil ^a   Kim, Jiyoung ^a   Kwon, Miyun ^a   Yu, Jaehoon ^a  

^a Seoul National University   (South Korea)

Author keywords

Artificial lectin; Cell surface carbohydrates; Lectin chip; Phage displayed peptide library; Specificity; Tentacle peptide

Indexed keywords

ALANYLHISTIDYLTRYPTOPHYLISOLEUCYLPROLYLARGINYLTYROSYLSERYLSERYLPROLYLAL ANYLTHREONINE; ASPARAGINYLPHENYLALANYLMETHIONYLGLUTAMYLSERYLLEUCYLPROLYLARGINYLLEUCYL GLYCYLMETHIONYLHISTIDINE; CARBOHYDRATE; GLUTAMINYLISOLEUCYLSERYLGLUTAMINYLARGINYLSERYLLEUCYLLEUCYLASPARTYLPROLYL LEUCYLLEUCINE; GLUTAMINYLPHENYLALANYLTHREONYLSERYLALANYLPROLYLPROLYLSERYLLEUCYLLEUCYL GLUTAMINYLLEUCINE; GLYCYLTHREONYLHISTIDYLLEUCYLISOLEUCYLALANYLGLYCYLGLYCYLALANYLSERYL HISTIDYLLEUCINE; HISTIDYLALANYLHISTIDYLSERYLTRYPTOPHYLPROLYLPROLYLALANYLHISTIDYLGLUTAMINYL LEUCYLHISTIDINE; HISTIDYLSERYLTHREONYLLEUCYLASPARTYLARGINYLARGINYLSERYLTHREONYLPROLYL PROLYLISOLEUCINE; LECTIN; LEUCYLASPARAGINYLALANYLSERYLGLUTAMINYLTYROSYLALANYLLEUCYLSERYLSERYL METHIONYLGLUTAMINE; LEUCYLTYROSYLMETHIONYLPROLYLPROLYLGLYCYLSERYLISOLEUCYLTYROSYLSERYLLEUCYL ASPARAGINE; PEPTIDE DERIVATIVE; SERYLHISTIDYLTRYPTOPHYLASPARTYLGLUTAMINYLPROLYLARGINYLPROLYLGLYCYLLEUCYL LYSYLPROLINE; SERYLISOLEUCYLSERYLTRYPTOPHYLGLUTAMINYLSERYLGLYCYLHISTIDYLPROLYL METHIONYLSERYLLEUCINE; TYROSYLASPARAGINYLPROLYLLEUCYLPROLYLGLUTAMINYLPROLYLSERYLVALYLTHREONYL THREONYLSERINE; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; DRUG BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; NONHUMAN;

BINDING SITES; BINDING, COMPETITIVE; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CELL MEMBRANE; LECTINS; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; PEPTIDE LIBRARY; PEPTIDES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750958467     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.09.035     Document Type: Article

References (36)

1. Hirabayashi J. Glycoconjugate J. 21 (2004) 35-40
2. Furukawa K., and Okajima T. Biochim. Biophys. Acta 1573 (2002) 377-381
3. Freeze H.H., and Aebi M. Curr. Opin. Struct. Biol. 15 (2005) 490-498
4. Laidler P., Litynska A., Hoja-Lukowicz D., Labedz M., Przybylo M., Ciolczyk-Wierzbicka D., Pochec E., Trebacz E., and Kremser E. Cancer Immunol. Immunother. 55 (2006) 112-118
5. Bironaite D., Nesland J.M., Dalen H., Risberg B., and Bryne M. Tumour Biol. 21 (2000) 165-175
6. Inzana T.J., Glindemann G., Cox A.D., Wakarchuk W., and Howard M.D. Infect. Immun. 70 (2002) 4870-4879
7. Saavedra E., Herrera M., Gao W., Uemura H., and Pereira M.A. J. Exp. Med. 190 (1999) 1825-1836
8. Peter-Katalinic J. Methods Enzymol. 405 (2005) 139-171
9. Medzihadszky K.F. Methods Enzymol. 405 (2005) 116-138
10. Lesinski G.B., and Westerink M.A. Curr. Drug Targets Infect. Disord. 1 (2001) 325-334
11. Kwon M., Jeong S., Lee K.H., Park Y.K., and Yu J. J. Am. Chem. Soc. 124 (2002) 13996-13997
12. Tam J.P. J. Immunol. Methods 196 (1996) 17-32
13. Carbohydrate-PAA-biotins, GlycoTech Corporation, USA, 2005.
14. BLAST search program .
15. Smith L.E., Uemura H., and Eichinger D. Mol. Biochem. Parasitol. 79 (1996) 21-33
16. Layh-Schmitt G., Hilbert H., and Pirkl E. J. Bacteriol. 177 (1995) 843-846
17. El-Sayed N.M., et al. Science 309 (2005) 409-415
18. Gerard C., Eddy Jr. R.L., and Shows T.B. J. Clin. Invest. 86 (1990) 1921-1927
19. Rimm D.L., and Morrow J.S. Biochem. Biophys. Res. Commun. 200 (1994) 1754-1761
20. Connor R.J., Kawaoka Y., Webster R.G., and Paulson J.C. Virology 205 (1994) 17-23
21. Buts L., Dao-Thi M.H., Loris R., Wyns L., Etzler M., and Hamelryck T. J. Mol. Biol. 309 (2001) 193-201
22. Vila-Perello M., Gutierrez Gallego R., and Andreu D. Chembiochem 6 (2005) 1831-1838
23. Shin I., Cho J.W., and Boo D.W. Comb. Chem. High Throughput Screen 7 (2004) 565-574
24. Fukui S., Feizi T., Galustian C., Lawson A.M., and Chai W. Nat. Biotechnol. 20 (2002) 1011-1017
25. Adler P., Wood S.J., Lee Y.C., Lee R.T., Petri Jr. W.A., and Schnaar R.L. J. Biol. Chem. 270 (1995) 5164-5171
26. Weis W.I., and Drickamer K. Annu. Rev. Biochem. 65 (1996) 441-473
27. Mammen M., Choi S.K., and Whitesides G.M. Angew. Chem., Int. Ed. 37 (1998) 2754-2795
28. Three natural lectins, Datura stramonium lectin (DSL), Erythrina cristagalli agglutinin (ECA), Ricin communis agglutinin (RCA), were purchased from Sigma and used without further purification. All of them are known to possess high affinities against N-acetyl-N-acetylglucosamine and N-acetyllactosamine.
29. Solid-phase peptide synthesis using Fmoc-Lys(biotin) as the first amino acid, followed by two Fmoc-Lys for the tetramer tentacle peptide. The synthesized peptides were purified by HPLC and identified by MULDI-TOFMS.
30. Sperandio M., Thatte A., Foy D., Ellies L.G., Marth J.D., and Ley K. Blood 97 (2001) 3812-3819
31. Ph.D. 12 Phage Display Peptide Library Kit, instruction manual, New England BioLabs, USA, 1997.
32. Kaiser E., Colescott R.L., Bossinger C.D., and Cook P.I. Anal. Biochem. 34 (1970) 595-598
33. Mortz E., Krogh T.N., Vorum H., and Gorg A. Proteomics 1 (2001) 1359-1363
34. Van Leeuwen H., Garcia-Mas J., Coca M., Puigdomenech P., and Monfort A. Mol. Genet. Genomics 273 (2005) 240-251
35. Connor R.J., Kawaoka Y., Webster R.G., and Paulson J.C. Virology 205 (1994) 17-23
36. Nadjar D., Rouveau M., Verdet C., Donay L., Herrmann J., Lagrange P.H., Philippon A., and Arlet G. FEMS Microbiol. Lett. 187 (2000) 35-40